Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US to weigh authorisation of Pfizer COVID vaccine for children aged five to 11
The panel's vote is an important regulatory step in getting the vaccine into the arms of millions of children in the US where…
Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1…
This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options
Review of Covaxin underway, expect a recommendation within 24 hours: WHO
The Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new…
Cipla announces Q2 FY22 results
Cipla has announced its unaudited consolidated financial results for quarter ended September 30th, 2021.
Key highlights of…
Cipla Health develops povidone iodine-based anti-viral nasal spray effective against coronavirus
Research shows that its main component PVP-I is effective against common respiratory tract infection-causing microbes including…
BD launches its second Centre of Excellence in flow cytometry for clinical research at CMC, Vellore
CMC Vellore will help to push the bounds of clinical research, provide opportunities for knowledge exchange and conduct diagnosis…
Bausch and Clearside Biomedical announce FDA approval of Xipere
Xipere is the first and only medicine to be approved in the US for delivery via suprachoroidal injection, a method designed to…
India committed to supplying COVID-19 vaccines to other nations by year end
The country had suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden…
Biological E hopes to roll out COVID vaccine by November-end
Biological E’s anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is currently undergoing phase-II/III…
EU regulator starts real-time review of Merck’s COVID-19 pill
Under the procedure, also known as a rolling review, the European Medicines Agency (EMA) would assess data as soon as it becomes…